Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Abbott Laboratories (ABT)

125.83   1.12 (0.9%) 01-21 17:34
Open: 126.81 Pre. Close: 124.71
High: 127 Low: 124.86
Volume: 10,124,997 Market Cap: 222,504M
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. It has collaboration agreement with Cereno Scientific AB (publ). The company was founded in 1888 and is based in North Chicago, Illinois.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 127.386 - 128.23 128.23 - 128.993
Low: 122.754 - 123.84 123.84 - 124.823
Close: 124.169 - 125.863 125.863 - 127.394

Technical analysis

as of: 2022-01-21 4:24:30 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 158.53     One year: 166.56
Support: Support1: 124.61    Support2: 103.68
Resistance: Resistance1: 135.73    Resistance2: 142.60
Pivot: 132.47
Moving Average: MA(5): 126.26     MA(20): 134.52
MA(100): 127.99     MA(250): 122.78
MACD: MACD(12,26): -2.13     Signal(9): -0.56
Stochastic oscillator: %K(14,3): 3.59     %D(3): 4.16
RSI: RSI(14): 31.24
52-week: High: 142.60  Low: 105.36  Change(%): 10.1
Average Vol(K): 3-Month: 5572  10-Days: 6628

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
ABT has closed above bottom band by 16.7%. Bollinger Bands are 91.2% wider than normal. The large width of the bands suggest high volatility as compared to Abbott Laboratories's normal range. The bands have been in this wide range for 4 bars. This is a sign that the current trend might continue.

Headline News

Thu, 20 Jan 2022
See Which Of The Latest 13F Filers Holds Abbott Laboratories - Nasdaq

Thu, 20 Jan 2022
Why Has Abbott Stock Dropped In January And Is A Rebound Likely? - Seeking Alpha

Wed, 19 Jan 2022
March 18th Options Now Available For Abbott Laboratories (ABT) - Nasdaq

Wed, 19 Jan 2022
Abbott Laboratories (ABT) Scheduled to Post Quarterly Earnings on Wednesday - MarketBeat

Sun, 16 Jan 2022
Will Demand for Rapid COVID-19 Tests Help Abbott Laboratories Beat the Market in 2022? - The Motley Fool

Fri, 14 Jan 2022
Abbott (ABT) Gets FDA Nod for New Cardiac Mapping System - Nasdaq

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 1,770
Shares Float (M) 1,750
% Held by Insiders 0.73
% Held by Institutions 75.38
Shares Short (K) 8,390
Shares Short P. Month (K) 8,710

Stock Financials

EPS 4.030
EPS Est This Year 2.500
EPS Est Next Year 2.820
Book Value (p.s.) 19.470
Profit Margin 17.12
Operating Margin 20.91
Return on Assets (ttm) 7.7
Return on Equity (ttm) 21.9
Qtrly Rev. Growth 23.4
Gross Profit (p.s.) 11.079
Sales Per Share 23.904
EBITDA (p.s.) 6.989
Qtrly Earnings Growth 70.50
Operating Cash Flow (M) 11,260
Levered Free Cash Flow (M) 8,130

Stock Valuations

PE Ratio 31.22
PEG Ratio
Price to Book value 6.46
Price to Sales 5.26
Price to Cash Flow

Stock Dividends

Dividend 1.800
Forward Dividend 1.880
Dividend Yield 0.01
Dividend Pay Date 2022-02-14
Ex-Dividend Date 2022-01-12
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.